- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.2: 27 residues within 4Å:- Chain A: V.27, A.28, I.35, G.36, D.37, G.38, R.39, S.40, I.41, G.77, R.78, K.79, T.80, L.99, S.100, S.101, T.102, G.130, G.131, I.154, G.155, G.156, G.157, S.158, V.159, Y.160
- Ligands: TMQ.3
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:I.41, A:T.80
- Hydrogen bonds: A:A.28, A:I.35, A:D.37, A:G.38, A:G.38, A:S.40, A:G.77, A:R.78, A:K.79, A:T.80, A:T.80, A:S.100, A:S.101, A:T.102, A:G.157, A:S.158, A:S.158, A:S.158, A:V.159, A:Y.160
- Salt bridges: A:R.78
NAP.7: 25 residues within 4Å:- Chain B: A.28, I.35, D.37, G.38, R.39, S.40, I.41, G.77, R.78, K.79, T.80, L.99, S.100, S.101, T.102, G.130, G.131, I.154, G.155, G.156, G.157, S.158, V.159, Y.160
- Ligands: TMQ.8
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:T.80, B:Y.160
- Hydrogen bonds: B:A.28, B:I.35, B:D.37, B:D.37, B:D.37, B:G.38, B:R.39, B:R.78, B:R.78, B:K.79, B:T.80, B:T.80, B:S.100, B:S.101, B:T.102, B:G.155, B:G.157, B:S.158, B:S.158, B:V.159
- Salt bridges: B:R.78
- 2 x TMQ: TRIMETREXATE(Non-covalent)
TMQ.3: 14 residues within 4Å:- Chain A: V.26, V.27, A.28, I.41, D.48, M.49, F.52, I.84, P.85, L.91, I.154, Y.160, T.178
- Ligands: NAP.2
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.41
- Hydrogen bonds: A:V.26, A:T.178, A:T.178
- Salt bridges: A:D.48
TMQ.8: 15 residues within 4Å:- Chain B: V.26, V.27, A.28, I.41, D.48, M.49, F.52, S.83, I.84, P.85, F.88, I.154, Y.160, T.178
- Ligands: NAP.7
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:I.41, B:F.52, B:I.84
- Hydrogen bonds: B:V.26, B:T.178, B:T.178
- Salt bridges: B:D.48
- 3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 2 residues within 4Å:- Chain A: R.233, R.235
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.233, A:R.233, A:R.235, A:R.235
EDO.5: 3 residues within 4Å:- Chain A: E.195, W.206, R.208
No protein-ligand interaction detected (PLIP)EDO.9: 2 residues within 4Å:- Chain B: R.233, R.235
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.233, B:R.233, B:R.235, B:R.235
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schormann, N. et al., Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function. Proteins (2008)
- Release Date
- 2009-01-06
- Peptides
- DHFR-TS: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x TMQ: TRIMETREXATE(Non-covalent)
- 3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schormann, N. et al., Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function. Proteins (2008)
- Release Date
- 2009-01-06
- Peptides
- DHFR-TS: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
D